ascendis pharma glp-1 receptor agonist Novo pens $285M biobucks deal to use Ascendis' tech to create monthly Novo Nordisk signs $285m deal
Pay in 4 interest-free payments of $6.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28



























